Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. November 2025 01:00 ET | Quelle: Molecular Partners

Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action

Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and metastatic lesions MP0712 Radio-DARPin leverages rapid...
11. November 2025 22:00 ET | Quelle: PyroGenesis Inc.

PyroGenesis Announces Third Quarter 2025 Results

MONTREAL, Nov. 11, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (TSX:PYR) (OTCQX:PYRGF) (FRA:8PY1), the leader in ultra-high temperature processes & engineering innovation, and a...
11. November 2025 15:31 ET | Quelle: PDS Biotechnology Corporation

PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering

PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
11. November 2025 14:27 ET | Quelle: Recordati

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION

NEWS RELEASE RECORDATI FIRST NINE MONTHS 2025 RESULTS:REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION Consolidated...
11. November 2025 09:30 ET | Quelle: Scilex Holding Company

Scilex Holding Company Announces that the Board of Directors of Datavault AI Inc. Has Approved the Distribution of a Dream Bowl 2026 Meme Coin to All Eligible Scilex and Datavault AI Stockholders of Record and Set a Record Date of November 25, 2025

PALO ALTO, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and...
11. November 2025 09:00 ET | Quelle: SAGA Metals Corp.

SAGA Metals Commences Drilling Campaign to Advance Mineral Resource Estimate at Radar Project in Labrador

SAGA Metals Commences Drilling Campaign to Advance Mineral Resource Estimate at Radar Project in Labrador
11. November 2025 08:51 ET | Quelle: Altimmune, Inc

Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025

24-week data demonstrated significant MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile Significant improvements observed in...
11. November 2025 08:16 ET | Quelle: Bleichmar Fonti & Auld

MLTX INVESTORS: MoonLake Immunotherapeutics Hit with Securities Class Action after 90% Stock Drop – Contact BFA Law by December 15 Court Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
11. November 2025 08:00 ET | Quelle: LIS Technologies Inc.

LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Announces Elite Level Sponsorship of the 2025 American Nuclear Society Winter Conference & Expo

Oak Ridge, Tennessee, Nov. 11, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented...
11. November 2025 08:00 ET | Quelle: March Biosciences, Inc

March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma

HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S....

Vorherige Seite

Nächste Seite